Skip to main content
. 2020 Oct 21;14(1):325–331. doi: 10.1093/ckj/sfaa137

FIGURE 3:

FIGURE 3:

Changes in urinary sodium excretion at baseline and at 1 and 3 weeks after the initiation of lenvatinib treatment in patients with and without fluid retention.